A company aimed at improving diabetes care has revealed during Diabetes Week that it has managed to save the NHS more than £25 million.
By supplying cost-effective meters, GlucoRx has managed to save the NHS money and offer diabetic patients a way to measure their blood glucose levels. The company formed in 2010 and its Nexus blood glucose testing system is the second most popular device in the country.
The company spoke about its achievement during Diabetes Week, which is organised by Diabetes UK and has the theme ‘Know Diabetes, Fight Diabetes’.
Chris Chapman, director of GlucoRx said: “As an innovative company we are always looking to push the barriers of science and healthcare and find ways to develop and deliver cost-effective products, which bring benefits to both people with diabetes and the NHS. We pride ourselves on prioritising patient care so profits can go towards extra nurses, newer equipment, greater research and be reinvested into care of the local community.
“Having saved the NHS over £25 million in the past three years the target now is to save the NHS £100 million. We are doing this by reaching out to more Clinical Commissioning Groups and Health Boards, which commission healthcare in the community, across the UK.”
The savings of £25 million were made in the past three years and have been calculated by using the NHS Prescription Cost Analysis and ePACT, an online application with 60 months of prescription data. The company is now aiming to save the NHS £100 million.
The company continues to work with a number of regional organisations to help raise awareness of diabetes, setting up a number of fundraising events for charities.